Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04069026
Title A First-in-Humans Dose Finding Study for an Aryl Hydrocarbon Receptor Inhibitor (AhRi) in Patients With Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP | DEU | CAN

Facility Status City State Zip Country Details
Yale University School of Medicine New Haven Connecticut 06520-8028 United States Details
Greenville Health System Greenville South Carolina 29605 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
South Texas Accelerated Research Therapeutics | START San Antonio San Antonio Texas 78229-3307 United States Details
Princess Margaret Hospital-University Health Network Toronto Ontario M5G 2M9 Canada Details
CHU de Québec-Hôpital de l'Enfant-Jésus Quebec G1J 1Z4 Canada Details
Universitätsklinikum Heidelberg Heidelberg Baden-Württemberg 69120 Germany Details
Universitätsklinikum Carl Gustav Carus Dresden Dresden Sachsen 01307 Germany Details
Charité Campus Benjamin Franklin (CBF) Berlin 12200 Germany Details
Institut Català d'Oncologia Hospitalet Hospitalet de Llobregat Barcelona 08907 Spain Details
Hospital Ramón y Cajal | Oncología Madrid 28034 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Universitario Virgen de la Victoria | Cardiology Department Málaga 29010 Spain Details
Hospital Clínico Universitario de Valencia Valencia 46010 Spain Details
Royal Marsden NHS Trust (Surrey) Sutton Surrey SM2 5PT United Kingdom Details
Beatson West of Scotland Cancer Centre Glasgow G12 0YN United Kingdom Details
Christie Hospital Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field